This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03515/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03515/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB03515/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03515/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03515/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03515
rdf:type
n3:Drug
n3:description
An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB03515 n14:DB03515
dcterms:title
Equilenin
adms:identifier
n8:DB03515 n10:EQU n11:392668 n12:444865 n13:46509080
n3:synthesisReference
Sigfrid Schwarz, "Equilenin derivatives, methods for producing the same and medicaments containing them." U.S. Patent US20040138194, issued July 15, 2004.
n3:IUPAC-Name
n4:271B4FB1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FB7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FB6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FB3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FB4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FB5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FAF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FAD-363D-11E5-9242-09173F13E4C5 n4:271B4FB0-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FAE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4FBD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4FBE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FB8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FB9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FBB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FBA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FBC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4FC3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4FC5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4FC6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4FC2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4FC1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4FC4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FB2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4FBF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4FC0-363D-11E5-9242-09173F13E4C5